Integrative and Emerging Models in Antibody Research: A Comprehensive Review
Antibody Therapeutics · 16.10.2025 · 8 (4) · 317-335
DOI: 10.1093/abt/tbaf018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibody Therapeutics, online erschienen am 28.08.2025. Verfasst von Jagadeeswara Reddy Devasani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biotechnology Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Antibody research has advanced through the integration of in vivo, in vitro, and in silico models, each offering distinct advantages and limitations. In vivo models, such as traditional animal models and humanized mouse models, provide critical insights into antibody efficacy and pharmacokinetics but face ethical and translational challenges. In vitro techniques, including hybridoma technology, phage display, and B-cell culture, enable efficient screening and optimization but often lack physiological relevance. In silico approaches, powered by computational biology and machine learning, accelerate antibody design and prediction, addressing challenges in cost and scalability. Emerging technologies like CRISPR-based engineering, single-cell sequencing, microfluidics, and organ-on-chip platforms are reshaping antibody discovery and therapeutic development. This review critically evaluates these models, emphasizing their integration to overcome existing challenges such as reproducibility, immunogenicity prediction, and scalability. As innovations continue, a multidisciplinary approach promises to enhance antibody research, driving next-generation therapeutics for cancer, autoimmune diseases, and infectious conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Biotechnology Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India.
- Pharmaceutical Chemistry Division, A.U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh 530003, India.
- GITAM School of Pharmacy, GITAM Deemed to be University, Rishikonda, Visakhapatnam, Andhra Pradesh 530045, India.
- Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (Deemed University), Manipal, Karnataka 576104, India.
ORCID-Profile: Jagadeeswara Reddy Devasani
Zitieren
APA
Devasani, J. R., Guntuku, G., Sarabu, P., Muthyala, M. K. K., Palla, M. S., & Subrahmanyam Volety, M. (2025). Integrative and Emerging Models in Antibody Research: A Comprehensive Review. Antibody Therapeutics, 8(4), 317-335. https://doi.org/10.1093/abt/tbaf018
Vancouver
Devasani JR, Guntuku G, Sarabu P, Muthyala MKK, Palla MS, Subrahmanyam Volety M. Integrative and Emerging Models in Antibody Research: A Comprehensive Review. Antibody Therapeutics. 2025;8(4):317-335. doi:10.1093/abt/tbaf018
BibTeX
@article{Devasani2025,
author = {Devasani, Jagadeeswara Reddy and Guntuku, Girijasankar and Sarabu, Prathyusha and Muthyala, Murali Krishna Kumar and Palla, Mary Sulakshana and Subrahmanyam Volety, Mallikarjuna},
title = {Integrative and Emerging Models in Antibody Research: A Comprehensive Review},
journal = {Antibody Therapeutics},
year = {2025},
volume = {8},
number = {4},
pages = {317--335},
doi = {10.1093/abt/tbaf018}
}
EUVIMED